Quali-Tea with Anne

In this episode, Paul Palmer shares insights on the common mistakes in designing pharmaceutical quality management systems and how to avoid them. Learn how to tailor your SOPs, map your processes, and engage your team for compliance and efficiency.

In this episode, Troy Fugate shares insights from Bio 2026, focusing on trends in the biotech industry, quality management, and the increasing role of AI. Discover key takeaways for professionals navigating regulatory and operational challenges in biotech.

In this inspiring interview, Carol Murray shares her remarkable journey of resilience, from surviving a plane fall to building a life dedicated to helping others develop resilience. Discover her unique 'Resilience Architecture' framework, emphasizing proactive preparation through core pillars like values, community, and perspective.

To hear Carol's full story listen to her first episode: https://podcasts.apple.com/us/podcast/the-power-of-perspective-carols-journey/id1613071519?i=1000696660968

Melissa Anders shares insights on managing burnout, leadership, and work-life balance for women in STEM. She discusses strategies for early-career and mid-career women to navigate challenges, develop leadership skills, and maintain authenticity.

Resources:

Melissa Anders - Coaching for Women in STEM - https://linkedin.com/in/melissaanders

In this episode, Anne MacNeil interviews John Fraser to explore the critical intersection of quality assurance, engineering, and regulatory compliance in the medical device industry. Discover insights on how quality is integrated from R&D to commercialization, the challenges of software regulation, and the evolving role of quality engineers in medtech.

**Key topics:**

- The role of quality in early product development and design controls

- Differences between R&D and engineering in medical device development

- When to implement design controls...

Summary

The conversation explores the significance of gratitude in corporate settings, highlighting the disparity between the desire to express gratitude and the actual execution of it. It delves into whether gratitude serves as a form of recognition or as a motivational tool for employees.

The conversation focuses on the importance of understanding and navigating Quality System Regulations (QSR) for companies in the industry. It emphasizes the need for gap assessments to identify compliance issues and the significance of aligning ISO structures with staff roles to ensure effective implementation and understanding of regulations.

Chapters

00:00 Introduction to QMSR and Compliance Insight

00:31 Steps for Companies to Prepare for QMSR

00:58 Benefits of QMSR Over QSR

"Understanding the customer journey is key to improving quality."

In this conversation, Anne MacNeil interviews James Warren, founder and CEO of Share More Stories, about the importance of authentic storytelling in understanding employee and customer experiences. They discuss how storytelling can bridge the gap between employee engagement and customer satisfaction, the innovative tools used to measure emotional responses, and the role of AI in analyzing feedback. James shares success stories from various industries, highlighting the transformative power of storytelling in enhancing quality and engagement.

To learn more check out:

https...

In this conversation, Anne MacNeil and Karina Lahnakoski explore the world of psychedelics, discussing their definitions, clinical applications, and the regulatory landscape surrounding them. They delve into the manufacturing and quality control challenges specific to psychedelics, operational considerations in production, and the differences between botanical and synthetic sources. The discussion also touches on the future of psychedelics in medicine, highlighting the growing interest and potential benefits for mental health treatment.

Takeaways

Psychedelics are psychoactive compounds that affect perception.

Classical psychedelics include psilocybin, LSD, and...

In this conversation, Anne MacNeil and Nu Trelle discuss the various pathways to accelerate drug approval, focusing on the role of the FDA and the importance of specific designations such as Fast Track, Breakthrough Therapy, and Orphan Drug Designation. They explore how these designations can expedite the drug development process, enhance patient access to innovative therapies, and the strategic considerations sponsors must take into account when navigating the regulatory landscape. The discussion emphasizes the need for safety and efficacy in drug development while ensuring timely access to treatments for patients in need.

Chapters

In this conversation, Anne MacNeil and Hannah Bauer explore the concept of human potential and its measurement within organizations. They discuss the importance of engagement, leadership, and communication styles in fostering a productive work environment. The conversation also highlights the significance of safety in manufacturing and the need for alignment between processes and human potential to achieve organizational goals.

To learn more about Hannah check out: https://heartnomics.com/

Takeaways

Human potential is often overlooked in organizations.

Engagement is critical for productivity and retention.

In this enlightening conversation, Anne MacNeil and Dianna Fioravanti-Ashikwe discuss the importance of women empowerment in leadership roles, the challenges women face in their careers, and the significance of authenticity and community support. Dianna shares her journey in male-dominated industries, the initiatives she has implemented to promote gender equality, and her insights on resilience and mentorship. The discussion emphasizes the need for women to embrace their unique strengths, build supportive networks, and leave a lasting legacy in their professional lives.

In this conversation, Anne MacNeil speaks with Dani Mason from B9 Creations about the intricacies of additive manufacturing, particularly in regulated industries such as aerospace and medical devices. They discuss the importance of quality assurance, regulatory challenges, and the innovative applications of 3D printing technology. Dani emphasizes the need for a robust quality management system and the role of real-time feedback in maintaining production standards. The conversation also touches on the training required for operators and the current trends in additive manufacturing, including bioprinting and personalized medicine.

In this episode, Anne MacNeil and Karina Lahnakoski discuss the latest trends and updates from Health Canada, focusing on the impact of government changes, drug shortages, new guidance documents, inspection trends, and the role of AI in the pharmaceutical industry. They also highlight the importance of addressing nitrosamines in drug products and the need for compliance with upcoming regulations.

The conversation provides an insightful overview of the final day of the Bio International Convention, highlighting key trends, innovations, and reflections from the event. Melissa and Troy discuss the noticeable absence of the FDA, the influx of international participants, and the growing interest in AI and startups. They also emphasize the importance of collaboration and investment in the biotech sector, showcasing the excitement and optimism surrounding new technologies and student involvement in the industry.

The conversation provides insights from the Bio International Convention, highlighting the busy atmosphere, networking opportunities, and the focus on technological innovations in the mRNA sector. The speakers discuss the challenges faced in delivery systems and quality compliance, emphasizing the importance of building trust and long-term partnerships in the industry. The regional representation and dynamics of the industry are also explored, showcasing the collaborative efforts and government support in advancing healthcare solutions.

In this episode, Anne MacNeil and Melissa recap day two of the Bio 2025 conference in Boston, discussing the significant themes of licensing and AI in biotech, and the importance of GMPs in research and development. They also touch on global engagement and the need for regulatory help for startups looking to enter the U.S. market.

In this episode, Anne MacNeil discusses the highlights from day one of Bio 2025 in Boston with Troy and Melissa from Compliance Insight. They explore the significant attendance, the absence of the FDA, emerging trends in the biotech industry, regulatory challenges, and the increasing role of AI in biotech. The conversation also touches on networking opportunities and the engagement strategies employed at the conference.

In this conversation, Peter Swimm discusses the integration of AI in quality management systems, emphasizing the importance of compliance and safety. He highlights the challenges faced by organizations in adopting AI technologies, particularly in regulated industries like healthcare. The discussion covers successful applications of AI, the necessity of data hygiene, and the importance of building effective AI tools that enhance quality management processes. Swimm also addresses common pitfalls in AI implementation and the need for continuous evaluation and adaptation of AI systems to meet compliance standards.

In this episode, Anne and Julio Martinez-Clark discuss the intricacies of conducting clinical trials in Latin America, focusing on medical device innovation. Julio shares his extensive experience in the field, highlighting the unique challenges faced by startups in navigating regulatory environments, patient recruitment, and quality management. The conversation delves into the importance of establishing quality standards and certifications for clinical research sites, as well as the technological advancements that are shaping the future of clinical trials in the region. Ultimately, the discussion emphasizes the need for speed and quality in trial execution to meet the demands of investors and...

In this conversation, Anne and Karina discuss the integration of AI in Quality Assurance (QA) and the lessons learned from data integrity requirements. They explore the regulatory landscape surrounding AI, its applications in drug discovery and clinical trials, and the importance of training and vendor qualification. The conversation highlights the potential risks associated with AI usage and emphasizes the need for proactive measures in organizations to ensure data integrity and compliance.

To learn more check out Karina's article on LinkedIn: https://www.linkedin.com/posts/activity-7284932351883632641-fOQ6?utm_source=social_share_send&utm_medium=member_desktop_web...

In this conversation, Anne and Mark Reich discuss the principles of Lean Thinking and the significance of Hoshin Kanri in strategic planning. Mark shares his extensive experience with Toyota and how it shaped his insights into effective management practices. The discussion covers practical applications of Hoshin Kanri, the importance of engaging people in the process, and the need for continuous monitoring and improvement to achieve organizational goals. Mark emphasizes the necessity of having a dedicated process owner to sustain the Hoshin Kanri methodology and shares success stories from various industries.

Check out more about...

In this conversation, Anne and Nu Trelle from Compliance Insight Inc. discuss the Abbreviated New Drug Application (ANDA) process, which allows for the approval of generic drugs in the US. They explore the history of ANDAs, the requirements for filing, the significance of bioequivalence studies, and the importance of the Chemistry, Manufacturing, and Controls (CMC) section. The discussion also covers the FDA review process, timelines, and post-approval steps necessary for bringing a generic drug to market.

In this inspiring conversation, Carol Murray shares her incredible journey from a life-altering skydiving accident to becoming a dynamic speaker and fundraiser for medical research. She discusses the challenges she faced during her recovery, the importance of safety and risk management, and the role of medical research in her healing process. Carol emphasizes the significance of perspective in overcoming adversity and finding purpose in life, encouraging others to learn from her experiences.

You can find out more about Carol at: https://www.carolmurray.ca/

In this conversation, Anne and Kathryn Munoz discuss the critical topic of patient access in healthcare, particularly in the biopharmaceutical industry. Kathryn shares her extensive experience in launching groundbreaking products and her recent transition to mental health with 4VITAHEALTH. They explore the challenges patients face in accessing medications, the importance of medication adherence, and how technology, including AI and telehealth, is transforming patient care. The discussion also touches on the integration of natural health solutions with traditional medicine and the evolving landscape of medical devices and patient support programs.

In this podcast episode, the hosts discuss the importance of quality management and knowledge transfer as they enter 2025. They reflect on past experiences with knowledge transfer, the challenges faced, and the evolving landscape of training, especially in the wake of virtual training methods adopted during the COVID-19 pandemic. The conversation highlights the need for effective strategies to ensure knowledge retention, especially in industries like pharma where regulatory compliance is critical. The hosts also explore the role of AI in enhancing training and knowledge management, and the importance of continuous improvement in these processes.

In this episode, the Quali-Tea team reflects on their predictions for 2024, discussing the accuracy of their forecasts regarding on-site audits, risk management, and the impact of AI in the pharmaceutical industry. They explore regulatory trends, investment dynamics, and emerging challenges, while also noting areas where their predictions fell short. The conversation highlights the evolving landscape of quality management and the importance of adapting to new developments in the industry.

In this enlightening conversation, Anne and Nu Trelle discuss the complexities of over-the-counter (OTC) medications, focusing on the regulations, approval processes, and the importance of compliance with OTC monographs. Nu Trelle shares insights from her extensive experience in the pharmaceutical industry, explaining the differences between OTC and prescription drugs, the significance of labeling for consumer safety, and the stringent requirements for bringing OTC products to market. The discussion also touches on the evolving nature of OTC monographs and the challenges faced by manufacturers in ensuring their products meet safety and efficacy standards.

In this conversation, Anne and Roger Smith delve into the world of robotic surgery and artificial intelligence, discussing the current landscape of surgical robots, the integration of AI in medical devices, and the regulatory challenges that accompany these advancements. They explore the implications of AI in surgical procedures, the role of independent robotic systems like the CyberKnife, and the future trends in robotic surgery. Additionally, they highlight the importance of quality professionals in navigating the evolving landscape of healthcare technology and regulatory requirements.

In this conversation, Anne and Daniel Charles from Compliance Insight discuss the three types of FDA 510k submissions: traditional, special, and abbreviated. They explore the requirements, benefits, and trends associated with each submission type, emphasizing the importance of understanding the 510k process for medical device manufacturers. Daniel shares insights on the review process, common issues faced during submissions, and tips for ensuring a successful review.

In this conversation, Anne and Michael Neece discuss the intricacies of handling difficult conversations, particularly in leadership and quality management contexts. They emphasize the importance of approaching these conversations with kindness, creating a safe environment, and being mindful of timing. Various feedback mechanisms are explored, including the sandwich principle and alternative methods that encourage self-reflection. The discussion also highlights the significance of self-forgiveness and maintaining a focus on the ultimate goal of quality assurance in patient care.

In this conversation, Anne and Dia Hill discuss the FDA's final rule on laboratory developed tests (LDTs), focusing on the implications for the industry, the shift in regulation, and the challenges laboratories face in compliance. They explore the phased implementation timeline, the need for training and resources, and the importance of regulatory assessments and classification of tests. The conversation highlights the global implications of these regulations and the necessity for laboratories to adapt to new quality systems and oversight requirements.

In this conversation, Anne and Melissa discuss the modernization of cosmetic regulation, specifically the Modernization of Cosmetics Regulation Act (MoCRA) of 2022. They cover the scope of the act, which includes all personal care items, and the increased responsibility it places on cosmetic companies. They also discuss the history of cosmetic regulation, the motivation behind the modernization, and the specific sections of the act that have already been implemented. Melissa highlights the challenges faced by companies, such as registration, adverse event reporting, safety substantiation, and mandatory recall. They also touch on the upcoming release of the good manufacturing practice (GMP...

In this conversation, Anne, Bethan, Kim, and Carol discuss the qualities and interview questions to consider when hiring for positions in quality. They highlight the importance of communication skills, interpersonal awareness, technical writing skills, and experience in quality. They also emphasize the need for collaboration, a risk-based mindset, and the ability to make decisive decisions. The conversation explores different interview styles, including situational questions, presentations, and written assessments. They also discuss the significance of follow-up emails and attention to detail in the interview process.

Michael Neese, president of Our Future is Kind, discusses the importance of kindness in building a good quality culture. He emphasizes the role of emotional stakes in driving people's behavior and the need for leaders to be tuned into the invisible forces underlying interactions. Neese explains that kindness is not just a warm and fuzzy concept, but a critical part of business that can boost productivity, innovation, and psychological safety within teams. He suggests practical tips for leaders, such as asking for feedback and creating a culture of collaboration, as well as tips for individuals to bring kindness into...

In this conversation, the hosts discuss the qualifications and process of becoming an auditor. They share their own experiences and highlight the importance of practical training, mentorship, and formal certifications. They also discuss the documentation of auditor qualifications and the need for ongoing education and staying current with regulations. The conversation concludes with the benefits of being a qualified auditor and the opportunities for learning and growth in this role.

In this episode, part two in the series on auditing. The hosts discuss the best way to close out an audit.

In this conversation, Anne, Kim, and Steven discuss where to start when conducting an audit. They suggest asking for a list of deviations, change controls, and out-of-specifications (OOS) results before going on the tour. They also recommend requesting these lists in an Excel format for easier searching. Other starting points include reviewing batch records, the site validation master plan, the quality manual or site master plan, and the standard operating procedure (SOP) list. They also emphasize the importance of looking at annual product reviews, overdue calibrations and preventive maintenance, and data integrity in computer systems. Additionally, they discuss the...

In this Q&A session, Anne answers questions about getting people on board with the value of quality incidents, handling a refusal to document changes, and managing audits efficiently. She suggests visually demonstrating the value of investigations and quantifying the cost of quality incidents to gain support. For documenting changes, she recommends simplifying the process, having change champions, and ensuring timely documentation. To manage audits effectively, Anne advises implementing an audit readiness program, preparing pre-prepared reports, and having subject matter experts ready.

The conversation explores work-life balance for quality professionals and provides tips for managing it. The speakers discuss the importance of scheduling breaks, setting boundaries, and prioritizing tasks. They also emphasize the need for flexibility in quality roles due to unexpected events and global work. The conversation touches on the challenges of technology and the availability of work at all times. The speakers suggest having a support system and recognizing burnout. They also highlight the importance of taking vacations and fully disconnecting from work.